Blog and Topics

Exhibition Report: BioJapan / Regenerative Medicine JAPAN / healthTECH JAPAN 2026

◆ Exhibition / Seminar Information ◆

Exhibition Report : INTERPHEX Week TOKYO2026 / Regenerative Medicine EXPO

<Blog 3>How to unlock Japan’s RM sector opportunity: the role of Japanese CDMOs

<Blog 2>Key considerations for unlocking Japan’s full cell & gene therapy and regenerative medicine potential

<Blog 1>Japan: A Unique Opportunity for Regenerative Medicine and Cell & Gene Therapy

◆Interview : BioPharma APAC "Teijin and Cell Therapies Forge a Cross-Border Alliance to Accelerate CGT Access Between Japan and Australia"

Exhibition Report : INTERPHEX Week TOKYO2025 / Regenerative Medicine EXPO

Teijin Regenet, TOHO HOLDINGS and ITOCHU Corp. Enter into Business Alliance Aimed at Building Novel Regenerative Medicine Ecosystem